Brief: Bioretec Resolves On Rights Issue Of About EUR 9.2 Mln
May 28 (Reuters) - Bioretec Oy BRETEC.HE: BIORETEC LTD'S BOARD OF DIRECTORS RESOLVED ON A RIGHTS ISSUE OF APPROXIMATELY EUR 9.2 MILLION AND PUBLISHES THE TERMS AND CONDITIONS OF THE FULLY GUARANTEED RIGHTS ISSUE SUBSCRIPTION PRICE FOR EACH NEW SHARE IS EUR 1.50 Source text: ID:nPrexYs8Ma Further company coverage: BRETEC.HE (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Bioretec Oy
See all newsBrief: Bioretec Initiates Change Negotiations
Brief: Bioretec Gets Marketing Authorization From FDA
Brief: Bioretec Receives FDA 510(K) Clearance For Its Activascrew Cannulated Com Bioabsorbable Compression Screw
Finland's Bioretec H1 revenue rises 12%, loss narrows
Brief: Bioretec Q2 Net Sales EUR 1.1 Million